Emergency department visits and hospitalizations for buprenorphine ingestion by children--United States, 2010-2011.

Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) received Food and Drug Administration approval in 2002 for the treatment of opioid dependence. Introduction of these drugs expanded the availability of opioid-dependence treatment options to reduce the morbidity and mortality associated with opioid abuse, and buprenorphine has become an increasingly prescribed component of office-based treatment. However, unsupervised ingestion of buprenorphine-containing products by children is a growing concern.

Citation

Centers for Disease Control and Prevention (CDC). Emergency department visits and hospitalizations for buprenorphine ingestion by children--United States, 2010-2011. MMWR. Morbidity and mortality weekly report. 2013 Jan 25;62(3):56

Mesh Tags

Substances

PMID: 23344700

search → result